PPIproton pump inhibitorSTSEosinophilic OesophagitisasthmaWelsh GovernmentStatsWales
…is, 50% of (n=46) patients were taking a proton pump inhibitor (PPI), 59% (n=54) were taking swallowed topical steroids (STS), 27% …
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,441–1,500 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
PDTx2Penthrox2SC-IFX2Sym0212Vilastobart2AB-30282BAR2BPA2Carnitine2FCM2HBIG2IXE2Icotrokinra2Idarucizumab2Meperidine2NIVO+IPI2Selexipag2Sucralfate2Trientine2Tulisokibart2VP-3152ZYN2aPD-12iNtercept2ACZ2ADA2Deucravacitinib2Endostatin2Etizolam2H1012Ianalumab2Nelmastobart2ON1012Omeprazole suspension2Plinabulin2SCAMP2Tolebrutinib2ZnT82interferon β-1a268Ga-FAPI2ASM2ATA2Afatinib2Avatrombopag2BAY29655012Carbetocin2DTx2FIT-positive2Glycine2HCB1012Ide-cel2MVA-BN2MitoQ2Mogamulizumab2Obe-502Optisol-GS2Osilodrostat2PMA2RAI2RZB2
Articles mentioning drugs
10,506 articles · page 397 of 876pembrolizumabadvanced non-small cell lung cancer
… patients with advanced non-small cell lung cancer who switched pembrolizumab from Q3W to Q6W between March 2017 and September 2023. Serum co…
ribavirinSofosbuvirhepatitis Ctertiary hospitalmalignancyrenal failureHCV cirrhosisblood transfusions
…Background Sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) is the current treatment regimen for hepatitis C (HCV) ci…
GPC3Glypican-3Hepatocellular carcinomaHCCPubMedChimeric antigen receptor T-cell (CAR-T) therapyGPC3-directed CAR-T therapyGoogle Scholar
…imeric antigen receptor T-cell (CAR-T) therapy directed against GPC3 has shown early antitumor activity in phase I trials; however, …
antibioticsATBadvanced malignanciesprobioticsFMTfecal microbiota transplantationATBimmunotherapy
…ival in cancer patients receiving ICIs from three perspectives: antibiotics (ATB), probiotics, as well as fecal microbiota transplantation …
CY01L. casei CY01Lacticaseibacillus casei CY01ARIIradiotherapyAcute radiation-induced intestinal injury (ARII)
…s in the gut environment following radiation. Administration of CY01 significantly alleviated symptoms of ARII and improved intestin…
Antibioticsimmune checkpoint inhibitorsICIsNSCLCnon-small cell lung cancerPubMedEmbaseWeb of ScienceCochrane Libraryimmunotherapy
…NSCLC, with no obvious evidence of publication bias.Conclusions Antibiotics and probiotics appear to exert opposite associations with immun…
DEN/CCl4DENHCCHepatocellular carcinomaTCGA
… lines (MIHA and HepLi5). HCC models were induced in mice using DEN/CCl4, DEN combined with a high-fat high-cholesterol diet (HFHCD), or…
biologicsinflammatory bowel diseaseIBD
…tients with inflammatory bowel disease (IBD) fail to respond to biologics, and no reliable biomarkers are currently available to predict …
proton pump inhibitorsCurcuminfunctional dyspepsia
…ed symptoms of functional dyspepsia with efficacy comparable to proton pump inhibitors, although the biological mechanisms remain unclear. This study …
warfarinAspirin12Clopidogrel1Pancreatic cancer10Ampullary cancer0Cholangiocarcinoma5Gallbladder cancer0Prince of Wales HospitalPancreatitis9
…6SD = standard deviation, CBD = common bile duct*Anticoagulant: warfarin, non-vitamin K antagonist oral anticoagulantsAbstract IDDF2026-…
PolypGenC4-EgyptC1-NorwayC5-ItalyC2-Franceinterval cancerC6-Norway
…t morphologically distinct polyp populations. Models trained on PolypGen are predicted to underperform in Asian-Pacific colonoscopy prog…